BioNexus Gene Lab Corp (BGLC)
Services-Medical Laboratories
Latest Price
$1.50
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
--
P/B Ratio
--
Valuation metrics
adjust assumptions →Base FCF: $247,928 (median of recent 5yr)
Growth: 5%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$2.78
+73% upside
Institutional Ownership
0.6% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| HRT FINANCIAL LP | 14.3K | -- | 0.59% | -- | 2026-06-30 |
| UBS Group AG | 101 | -- | 0.00% | -130 | 2026-06-30 |
| Caitong International Asset Management Co., Ltd | 1 | -- | 0.00% | -- | 2026-06-30 |